Clinical trial to evaluate the effect of Leucomycin A3 (Josamycin) in severe and very severe community-acquired pneumonia in Filipino children 2-5 years old ( a pilot study).
Phase 4
- Conditions
- severe and very severe community-acquired pneumonia
- Registration Number
- JPRN-UMIN000026440
- Lead Sponsor
- Teikyo University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who fulfill any of the followings are excluded 1.Patients with severe renal dysfunction (creatinine clearance is lower than 10mL/min) 2. Patients whom the treating doctor deems, for any reason, to be ineligible. 3. Patients with underlying heart conditions i.e. congenital heart disease. 4. The patient's LAR wants to stop the study,even if after the study have started.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mortality Duration of response to therapy Duration of signs and symptoms of the disease
- Secondary Outcome Measures
Name Time Method